Getting the Diagnosis Right

Why Can SFT Be Difficult to Diagnose?

SFT is a rare tumor that can develop almost anywhere in the body. Under a microscope, it can resemble several other types of tumors.

Depending on its location and appearance, SFT may initially be mistaken for another soft tissue tumor, a nerve sheath tumor, a gastrointestinal stromal tumor (GIST), or a tumor involving the coverings of the brain and spinal cord.

You may also see the older name hemangiopericytoma (HPC) in your medical records. Many tumors previously called HPC are now classified as SFT.

If your diagnosis has changed over time, it doesn’t necessarily mean someone made a mistake. Medical understanding and diagnostic methods have improved significantly.

The important question is whether your current diagnosis is supported by the available pathology findings.

How Doctors Confirm SFT

The diagnosis usually begins with a biopsy, in which a small sample of the tumor is removed and examined by a pathologist.

If you’ve already had surgery, the pathologist may examine tissue removed during the operation.

The pathologist looks at how the tumor cells appear under a microscope and may use special tests to help identify the tumor.

One of the most important tests for SFT is called STAT6 immunohistochemistry, often shortened to STAT6 IHC.

This test uses a special stain to look for the STAT6 protein inside tumor cells.

In most SFTs, the STAT6 protein appears strongly within the cell nucleus. This pattern is highly characteristic of SFT and helps distinguish it from many other tumors.

STAT6 staining is widely used because it is accurate and can usually be performed on existing biopsy or surgical tissue.

However, a positive STAT6 stain is not the only consideration. Your pathologist also evaluates how the tumor looks under the microscope and whether the findings fit with your clinical history.

Ask your doctor: Was STAT6 staining performed on my tumor, and do the results support the diagnosis of SFT?

Most SFTs contain a characteristic genetic change called the NAB2-STAT6 fusion.

This happens when parts of two genes become joined together, changing how tumor cells regulate their growth.

Special molecular tests can identify the fusion directly.

These tests can be particularly helpful when the pathology findings are unusual or the STAT6 staining is unclear.

Not everyone needs molecular fusion testing. When the microscopic findings and STAT6 staining are convincing, additional testing may not be necessary to establish the diagnosis.

If testing has been done, ask for a copy of the result and keep it with your pathology records.

What Is in Your Pathology Report?

Your pathology report contains more information than the name of your tumor.

Depending on the tissue available, it may include:

Some information may not be available from a small biopsy. For example, surgical margins can only be assessed after an operation, and a biopsy may not fully represent every part of the tumor.

Your doctor can help explain which findings are most important for your situation.

Several pathology findings help doctors estimate the likelihood that SFT may return or spread.

For many SFTs outside the brain and spinal cord, specialists use a risk assessment tool such as the Demicco model.

For SFT involving the coverings of the brain and spinal cord, a different grading system is generally used.

These tools help guide treatment and monitoring decisions, but they cannot predict exactly how an individual tumor will behave.

See Part 1: New Patient Guide for more about understanding your risk.

Do You Need More Genetic Testing?

You may hear about comprehensive genomic profiling, next-generation sequencing (NGS), or testing for genes such as TERT and TP53.

These tests look for additional genetic changes in the tumor.

Researchers are investigating how some of these changes relate to tumor behavior, treatment response, and the development of new therapies.

In certain situations, molecular profiling may also help identify research studies or clinical trials that could be relevant.

However, comprehensive genomic profiling is not required for every person with SFT, and the results do not always change treatment.

Your specialist can help you understand whether further testing would be useful.

The NAB2-STAT6 fusion can occur in several different forms, sometimes called fusion variants.

Researchers have found associations between certain variants and tumor location, appearance, and behavior. However, these findings are not yet reliable enough to guide treatment decisions on their own.

If your fusion variant has been identified, keep the result in your records. If it hasn’t, ask whether knowing it would be useful for your care or possible research participation.

You do not need to pursue additional testing simply to identify a fusion variant.

When Should You Consider a Pathology Second Opinion?

Because SFT is rare, a second opinion from a pathologist who specializes in sarcoma can be valuable.

It is especially worth discussing when:

• Your original diagnosis is uncertain or has changed.
• Your tumor has unusual features or test results.
• Your doctors are considering major treatment decisions.
• Your tumor has returned or is behaving differently than expected.
• Your pathology has not been reviewed by a specialist experienced with sarcoma.

A second opinion does not necessarily require another biopsy or a trip to another hospital.

In many cases, a specialist can review the tissue samples that were already collected.

1. Ask your doctor for a referral. You can request an outside pathology review at a sarcoma center.
2. Contact the reviewing center. Ask what reports, slides, or tissue samples they need and how the review is arranged.
3. Check insurance coverage. Ask about any costs, referrals, or prior authorization requirements.
4. Get a copy of the results. Keep the written review with your other medical records.

If the reviewing pathologist reaches a different conclusion, ask your care team to explain what changed and whether it affects your treatment plan.

After a biopsy or surgery, the pathology laboratory generally stores the tissue in preserved blocks, along with microscope slides.

These samples may be useful later for additional testing, review by another specialist, or research.

Ask your hospital where the tissue is stored and how long it will be retained.

You can also ask how samples can be requested if another medical center needs to review them.

Understanding Your Results

Pathology reports can be difficult to read. They contain specialized language, abbreviations, and details that may be unfamiliar.

You do not have to interpret the report yourself.

Ask your doctor to walk through the findings and explain what they mean for your care.

If you’re using an AI tool or online resource to help understand your report, compare the explanation with the original document. AI can sometimes misinterpret test results or leave out important details.

Use these tools to prepare questions, and ask your healthcare team to clarify anything you’re unsure about.

For help organizing your medical records and questions, see Preparing for a Visit.